These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28268248)

  • 21. BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
    Nam SK; Yun S; Koh J; Kwak Y; Seo AN; Park KU; Kim DW; Kang SB; Kim WH; Lee HS
    PLoS One; 2016; 11(3):e0151865. PubMed ID: 26991109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype.
    Jayasekara H; English DR; Haydon A; Hodge AM; Lynch BM; Rosty C; Williamson EJ; Clendenning M; Southey MC; Jenkins MA; Room R; Hopper JL; Milne RL; Buchanan DD; Giles GG; MacInnis RJ
    Int J Cancer; 2018 Jan; 142(2):238-250. PubMed ID: 28921583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Night-Shift Work Duration and Risk of Colorectal Cancer According to
    Shi Y; Liu L; Hamada T; Nowak JA; Giannakis M; Ma Y; Song M; Nevo D; Kosumi K; Gu M; Kim SA; Morikawa T; Wu K; Sui J; Papantoniou K; Wang M; Chan AT; Fuchs CS; Meyerhardt JA; Giovannucci E; Ogino S; Schernhammer ES; Nishihara R; Zhang X
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):133-140. PubMed ID: 31666286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between the dietary inflammatory index and all-cause mortality in colorectal cancer long-term survivors.
    Ratjen I; Shivappa N; Schafmayer C; Burmeister G; Nöthlings U; Hampe J; Hébert JR; Lieb W; Schlesinger S
    Int J Cancer; 2019 Mar; 144(6):1292-1301. PubMed ID: 30303515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary carbohydrate, glycemic index, and glycemic load in relation to risk of colorectal cancer in women.
    Larsson SC; Giovannucci E; Wolk A
    Am J Epidemiol; 2007 Feb; 165(3):256-61. PubMed ID: 17118965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA sequencing analysis reveals protective role of kruppel-like factor 3 in colorectal cancer.
    Wang X; Jiang Z; Zhang Y; Wang X; Liu L; Fan Z
    Oncotarget; 2017 Mar; 8(13):21984-21993. PubMed ID: 28423541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
    Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
    Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
    Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble tumour necrosis factor receptor type II and survival in colorectal cancer.
    Babic A; Shah SM; Song M; Wu K; Meyerhardt JA; Ogino S; Yuan C; Giovannucci EL; Chan AT; Stampfer MJ; Fuchs CS; Ng K
    Br J Cancer; 2016 Apr; 114(9):995-1002. PubMed ID: 27031855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
    Maierthaler M; Benner A; Hoffmeister M; Surowy H; Jansen L; Knebel P; Chang-Claude J; Brenner H; Burwinkel B
    Int J Cancer; 2017 Jan; 140(1):176-187. PubMed ID: 27632639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between pre-diagnostic leukocyte mitochondrial DNA copy number and survival among colorectal cancer patients.
    Yang K; Forman MR; Graham BH; Monahan PO; Giovannucci EL; De Vivo I; Chan AT; Nan H
    Cancer Epidemiol; 2020 Oct; 68():101778. PubMed ID: 32674053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
    Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M
    PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis.
    Chang SC; Lin PC; Lin JK; Lin CH; Yang SH; Liang WY; Chen WS; Jiang JK
    Ann Surg Oncol; 2016 Mar; 23(3):849-55. PubMed ID: 26471487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin B2 intake and colorectal cancer risk; results from the Nurses' Health Study and the Health Professionals Follow-Up Study cohort.
    Yoon YS; Jung S; Zhang X; Ogino S; Giovannucci EL; Cho E
    Int J Cancer; 2016 Sep; 139(5):996-1008. PubMed ID: 27081929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
    Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL
    Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals follow-up study.
    Kantor ED; Zhang X; Wu K; Signorello LB; Chan AT; Fuchs CS; Giovannucci EL
    Int J Cancer; 2016 Nov; 139(9):1949-57. PubMed ID: 27357024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality.
    Mehta RS; Chong DQ; Song M; Meyerhardt JA; Ng K; Nishihara R; Qian Z; Morikawa T; Wu K; Giovannucci EL; Fuchs CS; Ogino S; Chan AT
    Gastroenterology; 2015 Sep; 149(3):614-22. PubMed ID: 26026393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.